GHK-Cu significantly reduced inflammatory cytokines TNF-alpha, IL-6, and IL-1beta, enhanced mucosal repair, and upregulated tight junction protein expression through inhibition of the SIRT1/STAT3 signaling pathway
For more on this: Why Some Peptides Require Different Storage Conditions (And What That Means for Research) Peptide Half-Life Explained: Stability and Degradation in Laboratory Research Where Consistency Still Matters Even with peptides like DSIP, consistency plays a major role
BAC Water Complete Guide to Peptide Reconstitution, Mixing & Proper Preparation Techniques Learn how to properly use BAC Water to reconstitute peptides and injectable compounds
Lee SS, Kennedy S, Tolonen AC, Ruvkun G (2003) DAF-16 target genes that control C
Al-dulaimi, S., Thomas, R., Matta, S., & Roberts, T
The wound healing cascade and GHK-Cu: Normal wound healing occurs in four overlapping phases: Hemostasis clotting Inflammation immune cell recruitment Proliferation new tissue formation Remodeling scar maturation GHK-Cu appears to favorably influence phases 2, 3, and 4 simultaneously: In the inflammatory phase , it reduces pro-inflammatory cytokines (IL-6, TNF-) while preserving necessary immune signaling In the proliferative phase , it stimulates keratinocyte migration and fibroblast proliferation, accelerating epithelial coverage In the remodeling phase , it promotes type I collagen deposition over type III (scar) collagen, leading to better scar outcomes This multi-phase tissue repair activity makes GHK-Cu a compound of interest when studied alongside other regenerative peptides
